DNA Bioscience

DNA Bioscience was a United Kingdom DNA-testing company established in 2003. Its principal publicly described service was DNA paternity testing, positioning the business within the emerging consumer and legal DNA-analysis market. The company operated for only a short period and became widely known in 2005 not because of a major product expansion, but because of a political controversy involving the British politician David Blunkett. Blunkett purchased shares in DNA Bioscience. Shortly afterward, he became Secretary of State for Work and Pensions. He did not declare his financial interest in the company, creating a conflict-of-interest controversy over whether his investment should have been disclosed while he held ministerial office. The matter attracted substantial press attention and ultimately contributed to his resignation from the Cabinet in November 2005. DNA Bioscience's corporate life ended soon afterward. The company entered liquidation on 8 December 2005. Following the liquidation, its business was bought by a DNA-testing laboratory based in the United States, although the available reference material does not identify that purchaser by name or provide details of the transaction. The company is therefore best understood as a short-lived British DNA-testing brand whose historical significance is linked both to the early commercialization of paternity testing and to the political controversy surrounding its investor relationships.

DNA Bioscience was founded in the United Kingdom in 2003 as a DNA-testing company. Its documented business focus was DNA paternity testing, a service that uses genetic markers to assess whether a tested individual is the biological father of a child. At the time, paternity testing was becoming more accessible as a commercial service, with applications that could include personal inquiries and legal or administrative proceedings. The available historical material does not provide further detail about the company's laboratory infrastructure, management team, ownership structure, pricing, or geographic footprint. The company received an unusual level of public attention in 2005. David Blunkett, a prominent UK politician, had bought shares in DNA Bioscience. He subsequently became Secretary of State for Work and Pensions. His failure to declare the shareholding while serving in government raised questions about financial disclosure, ministerial ethics, and the potential appearance of a conflict of interest. The controversy became a prominent political story and was associated with Blunkett's resignation from the Cabinet in November 2005. DNA Bioscience's own corporate existence was brief. On 8 December 2005, the company entered liquidation. The business was subsequently bought by a DNA-testing laboratory based in the United States, but the available reference does not name the acquiring laboratory or explain whether the acquisition included the brand, laboratory operations, customer records, or other assets. No reliable information in the supplied material establishes continued use of the DNA Bioscience name after the liquidation. Accordingly, the brand is classified as defunct. The company's historical profile is consequently defined by three connected elements: its early-2000s UK DNA-paternity-testing business, the political controversy arising from an undeclared shareholding held by a senior politician, and its liquidation and subsequent purchase by an American DNA-testing laboratory. Beyond these events, publicly documented information about products, campaigns, executives, financial performance, and later corporate development is limited.

• 2005

  Shareholding controversy involving David Blunkett

  [1]DNA Bioscienceen.wikipedia.org

  David Blunkett's purchase of shares in DNA Bioscience, followed by his appointment as Secretary of State for Work and Pensions and failure to declare the interest, brings the company into national political and media attention.

• 2005

  Blunkett resigns from the Cabinet

  [1]DNA Bioscienceen.wikipedia.org

  The controversy surrounding the undeclared investment contributes to David Blunkett's resignation from the UK Cabinet in November 2005.

• 2005

  Liquidation and subsequent purchase

  [1]DNA Bioscienceen.wikipedia.org

  DNA Bioscience enters liquidation on 8 December 2005 and is subsequently bought by an American-based DNA-testing laboratory.

• 2003

  DNA Bioscience is founded

  [1]DNA Bioscienceen.wikipedia.org

  DNA Bioscience is established in the United Kingdom as a DNA-testing company focused on paternity testing.

A UK provider of consumer and potentially legal DNA paternity testing services during the early development of the commercial DNA-testing market.

• DNA testing service · 2003

  DNA paternity testing

  DNA Bioscience's principal documented offering was DNA paternity testing. The service used genetic analysis to evaluate a biological relationship between an alleged father and a child. The available source identifies the offering but does not specify the laboratory methodology, test format, turnaround time, accreditation, pricing, or whether individual tests were intended for legal use, personal information, or both.

• 2005

  Undeclared shareholding involving David Blunkett

  David Blunkett bought shares in DNA Bioscience and later served as Secretary of State for Work and Pensions without declaring his interest in the company. The resulting conflict-of-interest controversy attracted extensive press coverage and contributed to his Cabinet resignation in November 2005.

  Source

Read more

• 2005

  Enter liquidationOther

  Background

  After a short period of operation and the political controversy associated with the company, DNA Bioscience ceased operating as an independent business.

  Action taken

  The company entered liquidation on 8 December 2005.

  Aftermath

  The business was subsequently bought by an American-based DNA-testing laboratory. The identity of the purchaser and the precise assets transferred are not specified in the available reference.

  Source

1. 1DNA Bioscienceen.wikipedia.org